Loading interface...

New Triglucored Forte Tablet

Manufactured bySun Pharma Laboratories Ltd.
ContainsMetformin (500 mg) + Glibenclamide (5 mg) + Pioglitazone (15 mg)
Description
New Triglucored Forte Tablet is a combination of Metformin, Glibenclamide and Pioglitazone. It is an anti-diabetic medicine used for the treatment of type II diabetes in adults. It works by increasing insulin release and improving your body's response to insulin (a hormone that enables your body to use sugar). It also prevents the breakdown of carbohydrates to glucose (sugar) and thereby lowers your blood sugar levels. New Triglucored Forte Tablet may cause side effects like headache, dizziness, nausea, diarrhoea, etc. Consult your doctor if these symptoms persist or if they become severe. This medicine results in low blood sugar levels, and you may feel hungry, irritable, confused or anxious. New Triglucored Forte Tablet should be taken exactly as advised by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Do not skip a dose or discontinue the treatment as it may cause an increase in your blood sugar levels. New Triglucored Forte Tablet is not recommended if you are allergic to it. Inform your doctor if you have kidney, liver, or heart problems before beginning the treatment. This medicine is not recommended for use in children and adolescents below 18 years of age. Consult your doctor if you are pregnant, planning a pregnancy, or are breastfeeding.

Side effects

Major & minor side effects for New Triglucored Forte Tablet

  • Nausea and Vomiting
  • Heartburn
  • Abdominal fullness
  • Yellowing of skin and eyes
  • Fever or chills
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Unusual tiredness and weakness
  • Low blood sugar levels
  • Painful urination
  • Difficult and painful breathing
  • Irregular heartbeat
  • Weight gain
  • Headache
  • Fracture of bones

Uses of New Triglucored Forte Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of New Triglucored Forte Tablet can be observed within 15-60 minutes of intake.
  • How long do the effects of this medicine last?
    The duration for which New Triglucored Forte Tablet remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with New Triglucored Forte Tablet as it may increase the risk of lactic acidosis (increased blood lactic acid levels). It may also affect the ability of this medicine to control your blood sugar levels.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with New Triglucored Forte Tablet.
  • Can this medicine be taken during pregnancy?
    Due to a lack of sufficient safety and efficacy data, New Triglucored Forte Tablet is not recommended for use in pregnancy. Consult your doctor if you are pregnant or planning a pregnancy.
  • Can this medicine be taken while breast-feeding?
    New Triglucored Forte Tablet may pass into breastmilk. This medicine is not recommended while breastfeeding due to the increased risk of hypoglycaemia in your infant. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking New Triglucored Forte Tablet if you are allergic to it. However, seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.

Severe liver disease

Liver impairment is the loss of liver function. New Triglucored Forte Tablet is not recommended if you have liver problems due to increased risk of severe side effects.

Type I Diabetes mellitus

Type 1 diabetes, also known as insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin. Symptoms include increased thirst, frequent urination, hunger, fatigue, and blurred vision. New Triglucored Forte Tablet is not recommended if you have type 1 diabetes mellitus.

Severe kidney impairment

Kidney impairment is the loss of kidney function. New Triglucored Forte Tablet is not recommended if you have severe kidney problems as it may cause complications such as lactic acidosis (acid build up in the blood).

Metabolic Acidosis

Metabolic acidosis is characterized by high levels of acids in your blood. The symptoms include thirst, frequent urination, vomiting, abdominal pain, weakness, muscle cramps, etc. New Triglucored Forte Tablet is not recommended if you have metabolic acidosis as this medicine may worsen your condition.
Warnings for special population

Pregnancy

Due to a lack of sufficient safety and efficacy data, New Triglucored Forte Tablet is not recommended for use in pregnancy. Consult your doctor if you are pregnant or planning a pregnancy.

Breast-feeding

New Triglucored Forte Tablet may pass into breastmilk. This medicine is not recommended while breastfeeding due to the increased risk of hypoglycaemia in your infant. Consult your doctor if you are breastfeeding.
General warnings

Hypoglycemia

New Triglucored Forte Tablet may cause hypoglycaemia (decreased blood sugar levels). Regular monitoring of your blood sugar levels is recommended. Your doctor may advise you to carry a sugar candy to counteract the effects of low blood sugar levels when necessary.

Surgery

New Triglucored Forte Tablet is not recommended to be used during surgery due to the increased risk of lactic acidosis (high levels of lactic acid in the blood). If you are taking this medicine, inform your doctor before undergoing any surgery. Your doctor may suggest you to discontinue the treatment before surgery.

Change of medications

New Triglucored Forte Tablet may increase your risk of sleepiness and impaired thinking when taken with medicines that have a sedative effect. Inform your doctor about all your current medicines before beginning treatment with this medicine.

Use in children

New Triglucored Forte Tablet is not recommended for use in children and adolescents below 18 years of age due to a lack of safety and efficacy data.

Ovulation

New Triglucored Forte Tablet should be used with caution in premenopausal women due to the increase in chances of ovulation. Adequate contraceptive measures are recommended to avoid an unplanned pregnancy.

Driving or operating machines

New Triglucored Forte Tablet may cause low blood sugar levels and dizziness which may affect your mental alertness. Avoid driving vehicles or operating machines if you experience these symptoms after taking this medicine.

Missed Dose

Try not to skip a dose of New Triglucored Forte Tablet. Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.

Overdose

Do not take excess dose than prescribed by your doctor. Contact your doctor in case of an overdose with New Triglucored Forte Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with New Triglucored Forte Tablet as it may increase the risk of lactic acidosis (increased blood lactic acid levels). It may also affect the ability of this medicine to control your blood sugar levels.
Interaction with Medicine

Estradiol

Corticosteroids

Azole antifungal agents

Iodinated Contrast Media

ACE inhibitors

Disease interactions

Heart Disease

New Triglucored Forte Tablet should be used with caution if you have any pre-existing heart problems due to the increased risk of worsening your condition. Close monitoring of your heart function and vital signs is recommended.

Hemolytic Anemia/G6PD Deficiency

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition in which your red blood cells break down when exposed to certain medicines, infections, or stress. New Triglucored Forte Tablet is not recommended if you have this condition as it may result in haemolytic anaemia (low red blood cell count).

Bladder cancer

New Triglucored Forte Tablet is not recommended for use if you have active bladder cancer as this may increase the risk of serious side effects. Replacement with a suitable alternative should be considered under your doctor's supervision.

Vitamin B12 deficiency

New Triglucored Forte Tablet should be used with caution if you have vitamin B12 deficiency. This medicine interferes with the absorption of Vitamin B12 in your body. Consult your doctor if you are taking these medications together.
Food interactions
Information not available.
Lab interactions
Information not available.
Take New Triglucored Forte Tablet with food or as prescribed by your doctor. Avoid taking more than the prescribed dose as it may increase the risk of side effects. Avoid the discontinuation of New Triglucored Forte Tablet without consulting your doctor. Consult your doctor if you experience any undesirable side effects. Your dose is likely to change over time based on therapeutic response and clinical condition. Do not change the dose or duration of use without consulting your doctor. Regular follow-up visits with your doctor are recommended to evaluate your condition. Your doctor may suggest regular monitoring of your blood sugar levels to check that your diabetes is under control. Maintain a proper diet and do regular exercise to get maximum benefits of the treatment. You should always carry a sugar candy with you to counteract unexpected lowering of blood sugar levels.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
New Triglucored Forte Tablet is a combination medicine of Metformin, Glibenclamide and Pioglitazone. Metformin works by improving the body’s response to insulin and decreasing glucose (sugar) production in the liver. This helps in lowering the increased blood sugar levels. Glibenclamide works by increasing the release of insulin from the pancreas. Pioglitazone activates the peroxisome proliferator-activated receptor, resulting in the increased transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. This ultimately results in increased tissue sensitivity to insulin and decreased insulin resistance.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antidiabetic combinations

Schedule

Schedule H

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 2 December 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021178s015lbl.pdf>

Dailymed.nlm.nih.gov. 2021. DailyMed - METFORMIN HCL tablet. [online] Available at: < [Accessed 2 December 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d98aea3-35ba-447a-b88f-a5a20b612b2f>

Medsafe.govt.nz. 2021. [online] Available at: < [Accessed 2 December 2021].

http://www.medsafe.govt.nz/profs/Datasheet/d/Daoniltab.pdf>

Drugs, H., 2021. Pioglitazone: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 2 December 2021].

https://medlineplus.gov/druginfo/meds/a699016.html>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 3 Jan 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.